Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

被引:0
作者
E. Lin
Hans Garmo
Mieke Van Hemelrijck
Jan Adolfsson
Pär Stattin
Björn Zethelius
Danielle Crawley
机构
[1] School of Cancer and Pharmaceutical Sciences,Department of Clinical Science, Intervention and Technology
[2] Translational Oncology and Urology Research (TOUR),Department of Surgical Sciences
[3] King’s College London,Department of Public Health/Geriatrics
[4] Karolinska Institute,undefined
[5] Uppsala University,undefined
[6] Uppsala University,undefined
来源
BMC Cancer | / 20卷
关键词
Type 2 diabetes mellitus; Antidiabetic medication; Duration; Prostate cancer risk;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 262 条
[1]  
Crawley D(2018)Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study BMJ Open 8 e020787-381
[2]  
Garmo H(2015)Diabetes mellitus and risk of prostate cancer in the European prospective investigation into Cancer and nutrition Int J Cancer 136 372-186
[3]  
Rudman S(2013)Association between metabolic syndrome, diabetes mellitus and prostate cancer risk Prostate Cancer Prostatic Dis 16 181-1109
[4]  
Stattin P(2013)Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden Cancer Epidemiol Biomarkers Prevent 22 1102-74
[5]  
Zethelius B(2012)The association of diabetes and positive prostate biopsy in a US veteran population Prostate Cancer Prostatic Dis 15 70-1106
[6]  
Armes J(2016)Time-dependent risk of Cancer after a diabetes diagnosis in a cohort of 2.3 million adults Am J Epidemiol 183 1098-599
[7]  
Holmberg L(2012)Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle diabetes study Eur J Endocrinol 167 589-E502
[8]  
Adolfsson J(2013)The association between self-reported diabetes and cancer incidence in the NIH-AARP diet and health study J Clin Endocrinol Metab 98 E497-931
[9]  
Van Hemelrijck M(2008)Antidiabetic medication and prostate cancer risk: a population-based case-control study Am J Epidemiol 168 925-1020
[10]  
Tsilidis KK(2014)Metformin use and prostate cancer risk Eur Urol 66 1012-2837